Jazz Pharmaceuticals plc’s recent filing unveils that its EVP & Chief Legal Officer Patil Neena M unloaded Company’s shares for reported $0.46 million on Nov 08 ’24. In the deal valued at $123.41 per share,3,700 shares were sold. As a result of this transaction, Patil Neena M now holds 33,048 shares worth roughly $4.06 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Patil Neena M bought 3,700 shares, generating $456,632 in total proceeds.
Before that, COZADD BRUCE C sold 1,000 shares. Jazz Pharmaceuticals plc shares valued at $110,840 were divested by the Chairman & CEO at a price of $110.84 per share. As a result of the transaction, COZADD BRUCE C now holds 428,976 shares, worth roughly $52.67 million.
Goldman initiated its Jazz Pharmaceuticals plc [JAZZ] rating to a Buy in a research note published on June 05, 2024; the price target was $169. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who began to cover the stock in early January with a ‘”an Outperform”‘ rating. UBS also remained covering JAZZ and has decreased its forecast on November 27, 2023 with a “Neutral” recommendation from previously “Buy” rating. Raymond James started covering the stock on September 29, 2023. It rated JAZZ as “a Mkt perform”.
Price Performance Review of JAZZ
On Tuesday, Jazz Pharmaceuticals plc [NASDAQ:JAZZ] saw its stock fall -1.25% to $122.79. Over the last five days, the stock has gained 5.11%. Jazz Pharmaceuticals plc shares have fallen nearly -0.17% since the year began. Nevertheless, the stocks have risen 4.47% over the past one year. While a 52-week high of $134.17 was reached on 02/26/24, a 52-week low of $99.06 was recorded on 07/10/24. SMA at 50 days reached $114.17, while 200 days put it at $112.89.
Levels Of Support And Resistance For JAZZ Stock
The 24-hour chart illustrates a support level at 120.87, which if violated will result in even more drops to 118.94. On the upside, there is a resistance level at 124.16. A further resistance level may holdings at 125.52. The Relative Strength Index (RSI) on the 14-day chart is 56.79, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.48, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 46.48%. Stochastics %K at 72.25% indicates the stock is a holding.
How much short interest is there in Jazz Pharmaceuticals plc?
A steep rise in short interest was recorded in Jazz Pharmaceuticals plc stocks on 2024-11-15, growing by 0.32 million shares to a total of 3.82 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 3.49 million shares. There was a rise of 8.49%, which implies that there is a positive sentiment for the stock.
